Metabolic profile of indapamide sustained-release in patients with hypertension: data from three randomised double-blind studies.
2001
Objective: To evaluate the influence of indapamide sustained-release (SR) 1.5 mg/day, a thiazide-related sulfonamide diuretic, on serum levels of lipids (total cholesterol, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol and triglycerides), glucose and uric acid, and renal function (serum urea and creatinine levels).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
49
References
43
Citations
NaN
KQI